Eli Lilly has selected a leading USA-approved GMP provider to manufacture its groundbreaking medications, Retatrutide and Tirzepatide. This strategic decision highlights Lilly's commitment to quality in manufacturing and guarantees patients with access to safe and effective treatments. The chosen partner possesses a strong track record of meeting s